GSK files block listing for 250,000 new Ordinary Shares
GSK plc has applied to list 250,000 new Ordinary Shares of 31¼p each on the Financial Conduct Authority’s Official List and to trade them on the London Stock Exchange.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GSK plc has applied to list 250,000 new Ordinary Shares of 31¼p each on the Financial Conduct Authority’s Official List and to trade them on the London Stock Exchange. These shares are being reserved under a block listing for the GlaxoSmithKline plc Share Save Plan 2022, a plan that allows eligible employees to acquire shares in the company.
Admission of these shares is expected to become effective on 12 December 2025. Once issued, the new shares will rank equally with all existing GSK Ordinary Shares, meaning they will carry the same rights to dividends and voting as the current share capital.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did GSK (GSK) announce in this Form 6-K?
GSK plc announced that it has applied for 250,000 Ordinary Shares of 31¼p each to be admitted to the Financial Conduct Authority’s Official List and to trading on the London Stock Exchange.
Who signed this GSK (GSK) submission and in what capacity?
The report was signed by Victoria Whyte, acting as Authorised Signatory and Company Secretary on behalf of GSK plc.
AI-generated analysis. How Rhea-AI works. Not financial advice.
